Charlie’s (OTCMKTS:CHUC – Get Rating) is one of 59 public companies in the “Medicinals & botanicals” industry, but how does it compare to its peers? We will compare Charlie’s to related companies based on the strength of its dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations.
Profitability
This table compares Charlie’s and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Charlie’s | 8.40% | 69.27% | 25.33% |
| Charlie’s Competitors | -10.60% | -78.33% | 24.19% |
Earnings & Valuation
This table compares Charlie’s and its peers revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Charlie’s | $26.42 million | $4.81 million | -9.40 |
| Charlie’s Competitors | $266.77 million | -$99.45 million | -5.83 |
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Charlie’s and its peers, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Charlie’s | 0 | 0 | 0 | 0 | N/A |
| Charlie’s Competitors | 210 | 563 | 808 | 43 | 2.42 |
As a group, “Medicinals & botanicals” companies have a potential upside of 102.93%. Given Charlie’s’ peers higher probable upside, analysts plainly believe Charlie’s has less favorable growth aspects than its peers.
Volatility and Risk
Charlie’s has a beta of 4.66, indicating that its stock price is 366% more volatile than the S&P 500. Comparatively, Charlie’s’ peers have a beta of 1.14, indicating that their average stock price is 14% more volatile than the S&P 500.
Insider and Institutional Ownership
14.3% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 50.5% of Charlie’s shares are owned by company insiders. Comparatively, 22.6% of shares of all “Medicinals & botanicals” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Charlie’s beats its peers on 6 of the 10 factors compared.
Charlie’s Company Profile
Charlies Holdings, Inc. offers nicotine-only, e-cigarette and hemp-derived, CBD wellness liquid spaces through its subsidiary companies, Charlie’s Chalk Dust LLC and Don Polly LLC. It offers its products under the Pachamama and Charlie’s Chalk Dust brands. The company was founded by Brandon Stump and Ryan Stump in January 2001 and is headquartered in Costa Mesa, CA.
Receive News & Ratings for Charlie's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charlie's and related companies with MarketBeat.com's FREE daily email newsletter.
